From Heather DeVries at
Posts - Validation
May 28, 2016 11:38am
Here are the results of our latest Quick Question:
May 14, 2016 1:53pm
John Olson, MD, provides his position on the use of commercial plasmas for lot-to-lot validations (rollover) and for establishing reference intervals. Though associated with CAP, Dr. Olson's opinion does not necessarily reflect the official CAP policy.